Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis-Reference-Cited by-同舟云学术

Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis

Published:2019-05 Issue: Volume:163 Page:321-334
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

García-Martín Adela,Garrido-Rodríguez Martín,Navarrete Carmen,Caprioglio Diego,Palomares Belén,DeMesa Jim,Rollland Alain,Appendino Giovanni,Muñoz Eduardo^ORCID

Funder

MINECO

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference77 articles.

1. Current perspectives on the immunopathogenesis of systemic sclerosis;Fuschiotti;Immunotargets Ther.,2016

2. Pathogenesis of Systemic Sclerosis;Pattanaik;Front. Immunol.,2015

3. Pathologic observations in systemic sclerosis (scleroderma) A study of fifty-eight autopsy cases and fifty-eight matched controls;D'Angelo;Am. J. Med.,1969

4. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection;Cool;Hum. Pathol.,1997

5. Autopsy case of systemic sclerosis with severe pulmonary hypertension;Nagai;J. Dermatol.,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics in systemic sclerosis;Rheumatology International;2024-07-09

2. Patent review of cannabinoid receptor type 2 (CB ₂ R) modulators (2016-present);Expert Opinion on Therapeutic Patents;2024-07-02

3. Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling;Journal of Autoimmunity;2024-07

4. Neuroprotective effects of VCE-004.8 in a rat model of neonatal stroke;European Journal of Pharmacology;2024-06

5. Vasoactive and Antifibrotic Properties of Cannabinoids and Applications to Vasospastic/Vaso-Occlusive Disorders;Annals of Plastic Surgery;2024-06